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ABSTRACT 
 
Background:	A	small	percentage	of	patients	screen	positive	for	depression	following	a	mindfulness‐based	program.	
We	identified	patient	characteristics	associated	with	this	outcome	in	order	to	understand	this	phenomenon.	
Methods:	Depressive	symptoms,	stress,	mindfulness,	coping	with	illness	and	sense	of	coherence	were	measured	in	
126	patients	with	various	medical	and	psychological	conditions	pre‐	and	post‐	Mindfulness‐Based	Stress	Reduction	
(MBSR).	
Results:	Fewer	patients	 (27%	vs.	49%)	 screened	positive	 for	depression	post‐MBSR.	Both	pre‐	and	post‐MBSR	
patients	 who	 were	 depressive	 following	 MBSR	 scored	 lower	 on	 meaningfulness,	 comprehensibility,	 and	
manageability	(sense	of	coherence),	higher	on	emotional	coping	and	lower	on	palliative	and	distraction	coping.	
Smaller	positive	changes	(e.g.	stress)	occurred	in	these	patients	as	well.	Viewing	life	as	less	meaningful	pre‐MBSR	
predicted	more	symptoms	of	depression	post‐MBSR.	
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Conclusions:	Patients	who	suffered	depressive	symptoms	following	the	program	were	unable	to	reappraise	their	
lives	in	such	a	way	as	to	become	stress	resilient.
 
	
indfulness training has garnered much attention in the past decade as a way to help patients 
with chronic physical and psychological conditions to cope better with stress and illness1-6.  
Mindfulness-Based Cognitive Therapy (MBCT) has been included in the National Institute of 
Health and Clinical Excellence (NICE) guidelines in the UK as an evidence-based intervention to prevent 
depressive relapse7. MBCT uses the Mindfulness-Based Stress Reduction (MBSR) program as a blueprint. 
MBSR was developed in the United States in the late 1970s, and has been studied in much of the literature 
pertaining to mindfulness training. Published qualitative and systematic reviews (e.g. Bohlmeijer, Prenger, 
Taal, and Cuipers8; Grossman et al.9; Marchand10) indicate that MBSR relieves psychological distress, 
increases quality of life, and is beneficial for patients with various diseases11, 12. Toneatto and Nguyen13 
stated that mindfulness training does not have a reliable effect on depression and anxiety; however, this 
conclusion was critiqued by Hofmann et al.14 who conducted a rigorous meta-analysis and determined that 
both MBSR and MBCT are promising interventions for treating anxiety and depression in clinical 
populations.  
 
While the debate on the merits of this popular program continues, we are struck by the lack of attention to 
the possibility that some patients may feel worse following the program. One finds comments regarding 
there being “no undesirable side effects” (e.g. Merkes11) but these statements do not seem to be 
empirically-based. Dobkin et al.15 asked the question, “For whom may participation in a MBSR program be 
contraindicated?” to open a dialogue pertaining to this important issue.   
 
Here we examined data from 126 patients with various chronic illnesses who participated in the MBSR 
program offered between 2006 and 2012; while there were significant positive outcomes on most measures 
for the entire group16, a subgroup (n = 34) scored in the depressed range following the program. We  
compared pre- and post-MBSR differences between these patients and the 92 who did not screen positive 
for depression on stress, mindfulness, coping with illness, and sense of coherence to explore potential 
explanations for this finding. 
 
METHODS	
Patients	
Patients were recruited via the Internet, flyers in breast cancer clinics, and health care professionals who 
took our Mindfulness-Based Medical Practice workshop or 8-week course.  
M 
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Group formation was based on the Center for Epidemiologic Studies Depression Scale (CES-D)  
This 20-item scale is a screening tool for depression17. Scores range from 0 to 60, with a higher score 
indicating more symptoms of depression; the time frame is the past week for the population at large; 
according to the questionnaire founders a score of 16 or more indicates a positive screen for depression. 
The CES-D has good psychometric properties, with good internal validity and test-retest reliability.  For the 
present sample, the Cronbach’s alpha was .91 for both pre-MBSR and post-MBSR.  
 
Procedures	
All patients were interviewed by a clinical psychologist (PLD) with 25 years of experience treating patients 
with chronic illness and training in MBSR from the University of Massachusetts Center for Mindfulness. If a 
patient screened high on symptoms of depression before the program, a referral was made and/or 
appropriate treatment was recommended. The ethics committee of the McGill Faculty of Medicine approved 
the study and all patients signed an Informed Consent form. 
 
Intervention: Mindfulness-Based Stress Reduction Program  
The MBSR program18 was provided by the same instructor (PLD) to 11 different groups of 7-17 patients 
per group (mean=12 participants, SD=3), who met weekly for 2.5 hour classes for 8 consecutive weeks to 
learn mindfulness meditation and stress management techniques. Patients received a home practice 
manual and CDs created by the instructor to teach the following meditation practices: body-scan, sitting 
meditation, hatha yoga, and meditation involving visual imagery. Classes were structured and progressively 
taught means of coping with stress through meditation practice and dialogue about the practice in and out 
of the group meeting setting. Patients were asked to complete specific home practice exercises for 45-60 
minutes per day. As the program progressed, they selected which type of home practice was most suited 
to them. Informal practice (integrating mindfulness into daily activities) was also included in home 
assignments. Participation in a 6-hour silent retreat day, provided after the sixth class, was part of the 
program; it consolidated what had been learned throughout the program.  
 
Measures	
The Perceived Stress Scale-10 (PSS-10).  
The PSS-1019, 20 was developed to measure the extent to which respondents appraise situations in their life 
to be stressful during the past month. Each item is scored from 0 to 4, with scores ranging from 0 to 40; 
higher scores indicate a greater level of perceived stress. This scale has been shown to have good internal 
validity and test-retest reliability. For the present sample, Cronbach’s alpha was .89 for both times. 
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Coping with Health Injuries and Problems (CHIP).  
The CHIP, developed by Endler and Parker21, is a 32-item self-report questionnaire with scores that span 
a 5-point Likert scale, ranging from 1 = not at all, 3 = moderately, to 5 = very much. Respondents are asked 
how much they engage in various strategies when faced with health problems. There are four subscales: 
Distraction, which refers to the use of actions and cognitions that are aimed at avoiding preoccupation with 
the health problem; Palliative, which refers to engaging in self-care activities to alleviate the unpleasantness 
of the situation; Instrumental, which refers to focusing on task-oriented strategies to deal with illness (e.g., 
get information); Emotional, which refers to the extent to which one focuses on the emotional consequences 
of the health problem (e.g., get frustrated). The CHIP has good reliability and validity, and is considered a 
psychometrically sound measure of response to illness that is applicable across diverse patient populations. 
For the present sample, Cronbach’s alphas were .75 and .81 for pre- and post-MBSR for Distraction, 
respectively; .65 at both times for Palliative; .79 and .84 for Instrumental, pre-and post-MBSR, respectively; 
and .83 and .87 for Emotional, pre- and post-MBSR, respectively. 
 
Sense of Coherence (SOC).  
The SOC is a 29-item questionnaire that assesses the extent to which a respondent views their internal 
and external environments as structured, predictable, and manageable22. The Sense of Coherence 
questionnaire has three subscales: Comprehensibility, which refers to when the social world is interpreted 
by the respondent as rational, understandable, structured, ordered, consistent, and predictable; a sample 
item is: “When you face a difficult problem, the choice of a solution is: 1 = always confusing and hard to 
find, 7 = always completely clear.” Manageability, which involves the extent to which the respondent 
considers his or her coping resources to be available and adequate to deal with life’s challenges; a sample 
item is: “Do you have the feeling that you’re being treated unfairly? 1 = very often, 7 = very seldom or 
never”. Meaningfulness reflects whether a situation is appraised as challenging and worth investing in or 
making a commitment to cope with it. A sample item is: “Life is: 1 = full of interest, 7 = completely routine.” 
The SOC has good internal validity and good test-retest reliability. It has been used extensively in the study 
of health and well-being23. Cronbach’s alphas were .77 and .82 for Comprehensibility pre-and post-MBSR, 
respectively; .78 and .74 for Manageability pre- and post-MBSR, respectively; .88 for both times for 
Meaningfulness.  
 
Mindful Attention Awareness Scale (MAAS).  
Brown and Ryan24 developed the MAAS, a 15-item scale, to measure mindfulness, defined as a present-
centered attention to and awareness of accessible internal and external experiences. It has been shown to 
be inversely related to rumination, reported physical symptoms, and somatization. MAAS scores range from 
1 to 6, with higher scores reflecting greater degrees of mindfulness. The average MAAS score for a 
community sample is 4.22 (SD = 0.63). Cronbach’s alphas were .89 at both times. 
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Follow-up Questionnaire  
The follow-up questionnaire was developed by Kabat-Zinn and his colleagues. Patients were asked to 
indicate on a scale of 1 to 10 “how useful and beneficial” various components of the course (e.g., yoga, 
group discussions) were as well as how satisfied they were with the program.  
 
Statistical	Analysis	
Patients were divided into two groups based on their post-MBSR CES-D scores. A score of 16 or higher 
included patients who were in the depressive group (n = 34), while those who scored lower than 16 were 
in the comparison group (n = 92). Statistical tests were performed to determine if there were differences 
between groups at baseline. Independent samples t-tests were run on age and pre-MBSR PSS, MAAS, 
CHIP, and SOC scores. Chi-square analyses were run for gender, education, and primary diagnosis. 
Skewness and kurtosis were also checked for each variable. All variables were normally distributed except 
for post-MBSR CES-D, which was slightly skewed (skewness = 1.025).  
 
Two separate group-by-time repeated measures ANOVAs were performed for PSS and for MAAS. Two 
separate group-by-time repeated measures MANOVAs were performed for the four CHIP subscales and 
the three SOC subscales, respectively. Descriptive statistics were generated and main and interaction 
effects were examined. In all statistical tests, homogeneity of variance and compound symmetry were 
checked and Greenhouse-Geisser correction applied where necessary.  
A multiple linear regression analysis was performed to identify potential baseline predictors of post-MBSR 
CES-D scores; CES-D scores were no longer grouped by cut-off at 16, but used as a continuous variable. 
Both forward and backward selection methods were used to achieve a parsimonious model. Only variables 
detected by both methods were preserved.  
Finally, Pearson’s correlation coefficients were calculated for the change in mindfulness and outcome 
variables for each group separately. All analyses were performed with SPSS for Windows, version 12.0 
(2003). 
 
RESULTS	
Patients	
Table 1 shows the patient characteristics for both groups at baseline. There were no significant differences 
on gender or age. There were significant differences between the groups on diagnosis (Χ2 (4) = 17.97, p < 
.001), with the depressive group having fewer patients with breast cancer. Pre-post CES-D results showed 
that 34.9% were below the cutoff at both times; 6.3% worsened; 38.2% improved; and 20.6% were above 
the cutoff at both time points. 
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Variables CES-D < 16a  CES-D ≥ 16b  Statistic pc 
Demographics     
Sex (% female) 79 (85.9%) 29 (85.3%) Χ2 = .007 .94 
Age 52.01 (13.37) 53.06 (13.36) t = .39 .70 
Diagnosis (% breast cancer) 45 (48.9%) 14 (41.2%) Χ2 = 17.97 .001 
     
Questionnaires     
PSS 19.10 (6.30) 23.35 (6.29) t = 3.36 .001 
MAAS 3.74 (0.83) 3.68 (0.86) t = -.37 .71 
CHIP – distractive coping 26.08 (5.38) 21.29 (5.58) t = -4.31 .000034 
CHIP – palliative coping 23.57 (4.66) 24.62 (4.59) t = 1.13 .26 
CHIP – instrumental coping 33.01 (5.35) 31.68 (5.25) t = -1.25 .21 
CHIP – emotional coping 23.42 (7.23) 26.18 (7.33) t = 1.89 .06 
SOC – comprehensibility  42.55 (7.68) 38.32 (7.97) t = -2.72 .0075 
SOC – manageability 47.16 (6.31) 42.29 (8.16) t = -3.54 .00056 
SOC – meaningfulness 42.89 (6.95) 35.03 (8.93) t = -5.21 .0000008 
Table 1 Patient demographics and mean values of the questionnaires pre-MBSR  
a n = 92 
b n = 34 
c Bonferroni correction α=0.05/12 = 0.0042 
 
Separate repeated measures ANOVAs were performed to examine the effect of group and time on stress 
and mindfulness. For stress, there was a significant two-way interaction effect (F(1,124) = 16.82, p < 
0.0001) as well as significant main effects for time (F(1,124) = 36.96, p < 0.0001) and group (F(1,124) = 
51.08, p < 0.0001). Post-hoc analysis revealed that while the non-depressive group’s PSS score 
significantly decreased from pre- (mean = 19.10, SD = 6.31) to post-MBSR (mean = 12.89, SD = 4.54; p 
<0.001), there was no significant decrease in the depressive group (pre-MBSR mean = 23.35, SD = 6.29, 
post-MBSR mean = 22.15, SD = 5.47; p < 0.25).  
 
For mindfulness, there was a significant main effect for time (F(1,124) = 47.00, p < 0.0001) qualified by a 
significant two-way interaction (F(1,124) = 5.49, p = 0.02). There was no significant main effect for group. 
Post-hoc analyses revealed that there were significant increases for both groups over time. The depressive 
group increased from 3.68 (SD = 0.86) to 3.97 (SD = 0.74), and the non-depressive group from 3.74 (SD = 
.83) to 4.34 (SD = 0.65). Table 2 shows the results of the ANOVAs.  
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  CES-D < 16 (n = 92)  CES-D ≥ 16 (n = 34)   
 Pre Post da pb  Pre Post da pb  pintc 
            
PSS 19.10 
(6.31) 
12.89 
(4.54) 
1.13 0.000  23.35 
(6.29) 
22.15 
(5.47) 
0.20 0.25  0.00
0.00  
007 
            
MAAS 3.74 
(0.83) 
4.34 
(0.65) 
-0.80 0.000  3.68 
(0.86) 
3.97 
(0.74) 
-0.36 0.009  0.02
1.00 
Table 2 ANOVAs results for PSS and MAAS 
 a Effect sizes calculated using the following formula: Cohen’s d = Mpre - Mpost / SDpooled; large effect size equals >.08; medium effect 
size equals >.05; small effect size equals >.02. 
b p is based on mean difference (i – j), ANOVA 
c p interaction is based on the univariate tests of within-subjects interaction effect 
 
As shown in Table 3 separate, repeated measures MANOVAs were conducted for the four subscales of 
the CHIP and the three subscales of the SOC, respectively. Multivariate tests revealed significant two-way 
interactions for the CHIP (Wilk’s λ=0.92, F(4,121) = 2.79, p < 0.03) and main effects for time (Wilk’s λ=0.70, 
F(4,121) =13.17, p < 0.0001) and for group (Wilk’s λ=0.76, F(4,121) = 9.76, p < 0.0001). Univariate analyses 
revealed a significant two-way interaction for the palliative coping subscale (F(1,124) = 7.16, p < 0.008). 
Depressive patients decreased from 24.62 (SD = 4.59) to 23.15 (SD = 4.76), while non-depressive patients 
increased from 23.57 (SD = 4.66) to 24.49 (SD = 4.43). Further univariate analyses revealed significant 
time effects for the other three subscales: distractive coping (F(1,124) = 6.17, p < 0.014), instrumental 
coping (F(1,124) = 16.12,  p< 0.0001), and emotional coping (F(1,124) = 38.65, p < 0.0001). Two subscales 
showed significant between-subjects group effects for distractive coping (F(1,124) = 31.47, p < 0.0001) and 
emotional coping (F(1,124) = 8.87, p <0.003).  
 
 CES-D < 16 (n = 92) CES-D ≥ 16 (n = 34)   
CHIP 
subscales 
Pre Post da pb  Pre Post da pb  pintc 
            
Distractive 
coping 
26.08 
(5.38) 
24.81 
(5.80) 
0.23 0.000  21.38 
(5.58) 
21.74 
(5.18) 
-0.07 0.67  0.08 
Palliative 
coping 
23.57 
(4.66) 
24.49 
(4.43) 
-0.20 0.05  24.62 
(4.59) 
23.15 
(4.76) 
0.31 0.06  0.01 
Instrumental 
coping 
33.01 
(5.35) 
31.78 
(6.17) 
0.22 0.015  31.68 
(5.25) 
29.03 
(6.83) 
0.44 0.002  0.14 
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Emotional 
coping 
23.42 
(7.23) 
18.18 
(6.51) 
0.76 0.000  26.18 
(7.33) 
22.79 
(7.76) 
0.45 0.005  0.18 
Table 3 MANOVA results for CHIP 
Note: Multivariate F (4,121) = 2.79; Wilks’ Lambda = .916; p = .029 
a Effect sizes calculated using the following formula: Cohen’s d = Mpre - Mpost / SDpooled; large effect size equals >.8; medium effect 
size equals >.5; small effect size equals >.2. 
b p is based on mean difference (i – j), ANOVA 
c p interaction is based on the univariate tests of within-subjects interaction effect 
 
For the SOC subscales, there were significant two-way interactions and main effects. For the interaction, 
Wilk’s λ=0.91, F(3,122) = 3.98, p < 0.01. For the main effect of time, Wilk’s λ=0.81, F(3,122) = 9.51, p < 
0.0001, and for the main effect of group, Wilk’s λ=0.69, F(3,122) = 20.44, p < 0.0001. Univariate tests 
revealed significance on each of the three subscales: comprehensibility, F(1,124) = 8.89, p < 0.0035; 
manageability, F(1,124) = 8.52, p < 0.0042; and meaningfulness, F(1,124)=3.89, p < 0.051. Post-hoc 
analyses show that while comprehensibility, manageability, and meaningfulness for the non-depressive 
group significantly increased, they did not for the depressive group. There were also significant differences 
between groups at both time points as seen in Table 4. 
 
 CES-D < 16 (n = 92)  CES-D ≥ 16 (n = 34)   
SOC subscales Pre Post da pb  Pre Post da pb  pintc 
            
Comprehensibility 42.55 
(7.68) 
47.78 
(6.85) 
-0.72 0.000  38.32 
(7.97) 
39.09 
(7.38) 
-
0.10 
0.55  0.0035 
Manageability 47.16 
(6.31) 
50.45 
(5.16) 
-0.57 0.000  42.29 
(8.16) 
41.97 
(6.11) 
0.04 0.76  0.0042 
Meaningfulness 42.89 
(6.95) 
46.71 
(5.23) 
-0.62 0.000  35.03 
(8.93) 
36.68 
(8.08) 
-
0.19 
0.08    0.051 
Table 4 MANOVA results for SOC 
 
Note: Multivariate F (3,122) = 3.98; Wilks’ Lambda = .911; p = .0096 
a Effect sizes calculated using the following formula: Cohen’s d = Mpre - Mpost / SDpooled; large effect size equals >.08; medium 
effect size equals >.05; small effect size equals >.02. 
b p is based on mean difference (i – j), ANOVA 
c p interaction is based on the univariate tests of within-subjects interaction effect 
 
All results are shown graphically in Figures 1a-3c. 
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Fig 1a Means over time for post-MBSR depression subgroups for PSS   
 
Fig 1b Means over time for post-MBSR depression subgroups for MAAS 
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Fig 2a Means over time for post-MBSR depression subgroups for CHIP subscales 
 
Fig 2b Means over time for post-MBSR depression subgroups for CHIP subscales 
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Fig 2c Means over time for post-MBSR depression subgroups for CHIP subscales 
 
Fig 2d Means over time for post-MBSR depression subgroups for CHIP subscales 
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Fig 3a Means over time for post-MBSR depression subgroups for SOC subscales 
 
Fig 3b Means over time for post-MBSR depression subgroups for SOC subscales 
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Fig 3c Means over time for post-MBSR depression subgroups for SOC subscales 
 
Multiple linear regression analyses were performed using baseline CES-D as a continuous variable and 
PSS, CHIP subscales, and SOC subscales as putative predictors. Only the SOC subscale meaningfulness 
was significant in both forward and backward models. Using the forward method, the adjusted R2 = 0.28, 
F(1,124) = 50.02, p < 0.001, and β = -0.54. Using the backward method, the adjusted R2 = 0.29, F(2,123) 
= 26.91, p < 0.001, and β = -0.45. Higher meaningfulness before the course predicted less depressive 
symptoms after the course. 
 
As shown in Table 5, Pearson’s correlation coefficients were calculated between MAAS change scores and 
PSS, CHIP, and SOC change scores. For the depressive group, only the SOC meaningfulness change 
score was significant (p < 0.007), whereas for the non-depressive group, there were significant correlations 
at the p = .01 for: stress, emotional coping, and the three subscales of the SOC. 
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Table 5 Correlation between MAAS change score and outcome variables 
 
*Correlation is significant at the 0.05 level (2-tailed). 
**Correlation is significant at the 0.01 level (2-tailed). 
 
Follow‐Up	Questionnaire	
When asked participants to rate the course overall and found that there was little difference between 
groups. Their scores of 8.6 and 9.1/10 (depressive and others, respectively) indicated that they were 
satisfied with the course. The top three course components rated as important for the depressive patients 
were: awareness of breath, yoga (with CD), and retreat day; for the comparison group, it was: awareness 
of breath, retreat day and yoga (with CD). 
 
DISCUSSION		
There is a burgeoning literature examining processes through which patients benefit from mindfulness-
based interventions25-28. For example, in a comparison of MBSR, MBCT, and Zen meditation, Marchand10 
presents psychological mechanisms proposed to underlie improvements. “Reperceiving” (a fundamental 
shift in perspective such that one is able to step back from, and be less identified with one’s own thoughts 
and emotions) is purported to be one way that becoming more mindful can reduce distress29. This notion 
was supported in a qualitative study of MBSR participants’ diary entries in a small community sample of 
women30 as well as an examination of a subset (n = 13) of the cohort in the present study31. Equally 
important may be reductions in self-referential thinking, especially narrative self-reference that perpetuates 
negative self-judgments and dsyphoria32. Several studies have shown that increases in mindfulness are 
associated with decreases in rumination33-35 and increases in mindfulness have been hypothesized to 
moderate outcomes (e.g. stress reduction)28. For example, in a study of physicians and health care 
professionals increases in self-compassion and mindfulness both independently predicted well-being36. 
Variables Depressed (n=34) Non-depressed (n=92) 
PSS -.22 -.48** 
CHIP    
Distractive coping .31 .22* 
Palliative coping  .17 .06 
Instrumental coping .03 .20 
Emotional coping -.27 -.38** 
SOC   
Comprehensibility .27 .45** 
Manageability .31 .35** 
Meaningfulness .46** .47** 
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The full sample in the present cohort showed significant improvements on outcome measures (stress, 
depression) and process measures (mindfulness, sense of coherence, and coping)16. While the comparison 
group improved on stress the depressive group remained highly symptomatic at both times. 
 
Palliative coping changed in opposite directions for the two groups. If one considers palliative coping as an 
expression of self-compassion then this finding is of interest as it has been suggested that self-compassion 
partially mediates the relationship between mindfulness and well-being37. The depressive patients 
decreased this approach from pre- to post-MBSR. As for the other coping strategies, those who reported 
more depressive symptoms had significantly lower scores on distraction and higher levels of emotional 
coping at both time points. Distraction coping assesses actions and cognitions that are aimed at avoiding 
preoccupation with the health problem (e.g. engaging in unrelated activities; being in the company of 
others). With emotional coping the patient focuses on the emotional consequences of the health problem; 
items include responses reflecting self-preoccupation and catastrophizing. With regard to sense of 
coherence, those with depressive symptoms were significantly lower at both times. Thus, they perceived 
themselves to be overwhelmed by life and coped poorly with the challenges they were facing.  
 
Results from the regression analysis indicated that meaningfulness was the sole predictor of depression 
(as a continuous variable). Garland et al.29 provide a plausible interpretation for this finding. When a person 
can reappraise a stressful event as being meaningful (e.g. a cancer survivor views the illness experience 
as a “wake-up call”), then negative emotions can be regulated more effectively. In their study of 339 patients 
who took MBSR it was shown that the stress-reductive effects of increases in mindfulness were partially 
mediated by growth in positive reappraisal. It would appear that patients in our study were unable to 
perceive stressors in another light, as reflected by high stress post-MBSR, emotional coping and lower 
scores on all subscales of the SOC questionnaire; this may have influenced their ability to regulate their 
moods. 
 
Both groups increased over time on mindfulness but the depressive group scores were significantly lower 
than the comparison group post-MBSR. This finding may be important as mindfulness has been found to 
develop experiential self-reference, which is viewed as adaptive10. Those who ruminate engage in narrative 
self-reference and this is linked to affective disorders. The correlations between changes in mindfulness 
and outcomes differed by group as well. For the depressive patients, the only significant correlation was 
with meaningfulness. For the comparison group, increases in mindfulness were significantly related to 
changes in: emotional coping, stress, and all three subscales of the SOC measure.  
 
Our findings suggest that MBSR may have limited benefits for some patients who are currently depressed 
and alternative approaches to mindfulness training may be considered. While MBCT appears the natural 
choice there are caveats to consider. MBCT was designed for patients whose depression was in remission 
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and results show that not all benefit in terms of relapse prevention32,38. Specifically, patients who had 
suffered less than two previous depressive episodes appeared not to benefit greatly39, 40. Yet, restricting 
MBCT to such patients has been disputed, with the suggestion that residual depressive symptoms, 
regardless of previous number of episodes may be improved41. Some patients in our group could be 
considered “treatment resistant” and adaptations of MBCT have been successfully used in such patients42.  
 
We do not know yet how to determine a priori who will benefit from which type of mindfulness-based 
therapy. Few studies have examined pre-program patient variables that may predict outcomes (e.g. 
mindfulness; Shapiro et al.28). Perhaps more time is needed to make changes to long-standing cognitive 
habits or specific exercises like those found in Cognitive Behavior Therapy (CBT) may be necessary. A 
broader question concerns whether mindfulness training of any kind is an appropriate therapeutic strategy 
for currently depressed patients. For some it may be more appropriate to use another form of evidence-
based psychotherapy first and consider mindfulness training following remission of acute symptoms5. 
 
Clinical	Implications	
Considering the current surge of interest in mindfulness training, referring clinicians should caution patients 
of the possibility of depressive symptoms arising. Additionally it may be appropriate to offer MBCT, CBT or 
antidepressant medication instead of MBSR, to patients with current depressive symptoms.  
 
Limitations	
While we do not claim to have diagnosed patients, scores on the CES-D were elevated enough to suggest 
that for many, clinical depression may have been present. We did not have however, information on the 
number of previous depressive episodes or the treatments attempted pre-MBSR. Second, the way the high 
depressive symptom group was defined did not capture improvements among some patients whose scores 
were very high pre-MBSR and were reduced, albeit not below 16, post-MBSR. Lacking long-term outcomes, 
we cannot know if patients improve with time and more practice. Moreover, we did not collect data on home 
practice so we do not know if this varied by group or made a difference for outcomes. Finally, as is often 
the case with MBSR courses, there were relatively few men enrolled. This is partially due to the fact that 
the course was offered to women recovering from breast cancer.  
 
CONCLUSION	
We recommend that the question who may feel worse and why following MBSR be considered. Moreover, 
how to help those who feel that life is meaninglessness needs to be contemplated. We do not advocate 
excluding patients on this basis as this may reinforce their low sense of coherence and perhaps cause 
harm. We need to reflect on how to assist them reappraise their lives or recognize and accept the fact that 
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finding meaning takes time and patience. This could be discussed during the pre-MBSR interview when 
scores on this variable are low.■ 
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